Can an immune booster delay HIV treatment?
NCT ID NCT00120185
First seen Apr 06, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study tested whether giving interleukin-2 (IL-2) injections to HIV patients who had never taken antiretroviral drugs could help keep their CD4 cell counts high and delay the need for standard HIV therapy. The trial enrolled 130 adults with CD4 counts between 300 and 500. Researchers measured how many patients saw their CD4 count drop below 300 over 96 weeks. The goal was to see if IL-2 could control the disease without lifelong medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service des Maladies Infectieuses
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.